Pibrentasvir
目录号: A22474
HCV NS5A 抑制剂
Pibrentasvir,也被称为 ABT-530,是一种蛋白酶抑制剂,可能用于治疗 HCV(丙型肝炎病毒)感染。
HCV NS5A 抑制剂
Discription | Pibrentasvir, also known as ABT-530, is a protease inhibitor potentially for the treatment of HCV infection. |
---|
目录号 | A22474 |
---|---|
分子式 | C57H65F5N10O8 |
分子量 | 1113.2 |
CAS号 | 1353900-92-1 |
SMILES | FC1=CC=C(C=C1)C2CCN(CC2)C3=C(C=C(C=C3F)N4[C@H](CC[C@@H]4C5=C(F)C=C6NC([C@@H]7CCCN7C([C@@H](NC(OC)=O)[C@H](OC)C)=O)=NC6=C5)C8=C(C=C9C(N=C([C@@H]%10CCCN%10C([C@@H](NC(OC)=O)[C@H](OC)C)=O)N9)=C8)F)F |
其他名称 | ABT-530, ABT530, ABT 530, A-1325912, A 1325912, A1325912, A-1325912.0, A 1325912.0, A1325912.0, Pibrentasvir. |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2